1. Home
  2. Labeler Index
  3. Glaxosmithkline Biologicals Sa
  4. 58160-827
  5. NDC Package Code: 58160-827-30 Menveo

NDC Package 58160-827-30 Menveo

Meningococcal (groups A,C,Y And W-135) Oligosaccharide Diphtheria Crm197 Conjugate Vaccine - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
58160-827-30
Package Description:
10 VIAL in 1 CARTON / .5 mL in 1 VIAL (58160-827-03)
Product Code:
58160-827
Proprietary Name:
Menveo
Non-Proprietary Name:
Meningococcal (groups A, C, Y And W-135) Oligosaccharide Diphtheria Crm197 Conjugate Vaccine
Substance Name:
Neisseria Meningitidis Group A Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen; Neisseria Meningitidis Group C Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen; Neisseria Meningitidis Group W-135 Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen; Neisseria Meningitidis Group Y Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen
Usage Information:
MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. MENVEO is approved for use in persons aged 2 months through 55 years.MENVEO does not prevent N. meningitidis serogroup B infections.
11-Digit NDC Billing Format:
58160082730
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 901514 - meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine (MCV4 generic for Menveo) 0.5 ML Injection
  • RxCUI: 901514 - 0.5 ML Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection
  • RxCUI: 901514 - meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine 0.5 ML Injection
  • RxCUI: 901518 - MENVEO vaccine 0.5 ML Injection
  • RxCUI: 901518 - 0.5 ML Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection [Menveo]
    • Product Type:
    Vaccine
    Labeler Name:
    Glaxosmithkline Biologicals Sa
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
    • Active Ingredient(s):
  • NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 10 ug/.5mL
  • NEISSERIA MENINGITIDIS GROUP C CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 5 ug/.5mL
  • NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 5 ug/.5mL
  • NEISSERIA MENINGITIDIS GROUP Y CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 5 ug/.5mL
    • Pharmacologic Class(es):
  • Actively Acquired Immunity - [PE] (Physiologic Effect)
  • Actively Acquired Immunity - [PE] (Physiologic Effect)
  • Inactivated Meningococcal Vaccine - [EPC] (Established Pharmacologic Class)
  • Meningococcal Vaccines - [CS]
  • Vaccines, Inactivated - [CS]
    • Sample Package:
    No
    FDA Application Number:
    BLA125300
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    12-09-2022
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 58160-827-30?

    The NDC Packaged Code 58160-827-30 is assigned to a package of 10 vial in 1 carton / .5 ml in 1 vial (58160-827-03) of Menveo, a vaccine label labeled by Glaxosmithkline Biologicals Sa. The product's dosage form is injection, solution and is administered via intramuscular form.

    Is NDC 58160-827 included in the NDC Directory?

    Yes, Menveo with product code 58160-827 is active and included in the NDC Directory. The product was first marketed by Glaxosmithkline Biologicals Sa on December 09, 2022 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 58160-827-30?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 58160-827-30?

    The 11-digit format is 58160082730. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-258160-827-305-4-258160-0827-30